102 related articles for article (PubMed ID: 9376479)
21. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
22. Comorbidity in newly diagnosed thyroid cancer patients: a population-based study on prevalence and the impact on treatment and survival.
Kuijpens JL; Janssen-Heijnen ML; Lemmens VE; Haak HR; Heijckmann AC; Coebergh JW
Clin Endocrinol (Oxf); 2006 Apr; 64(4):450-5. PubMed ID: 16584519
[TBL] [Abstract][Full Text] [Related]
23. Population-based outcomes for pediatric thyroid carcinoma.
Shapiro NL; Bhattacharyya N
Laryngoscope; 2005 Feb; 115(2):337-40. PubMed ID: 15689762
[TBL] [Abstract][Full Text] [Related]
24. The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma.
Zaydfudim V; Feurer ID; Griffin MR; Phay JE
Surgery; 2008 Dec; 144(6):1070-7; discussion 1077-8. PubMed ID: 19041020
[TBL] [Abstract][Full Text] [Related]
25. The relation between pure papillary and follicular variant in papillary thyroid carcinoma.
Yuksel O; Kurukahvecioglu O; Ege B; Ekinci O; Aydin A; Poyraz A; Tezel E; Taneri F
Endocr Regul; 2008 Mar; 42(1):29-33. PubMed ID: 18333702
[TBL] [Abstract][Full Text] [Related]
26. Findings of computerised nuclear morphometry of papillary thyroid carcinoma in correlation with known prognostic factors.
Tseleni S; Kavantzas N; Yova D; Alexandratou E; Karydakis V; Gogas J; Davaris P
J Exp Clin Cancer Res; 1997 Dec; 16(4):401-6. PubMed ID: 9505213
[TBL] [Abstract][Full Text] [Related]
27. Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited.
Kebebew E; Treseler PA; Ituarte PH; Clark OH
World J Surg; 2001 May; 25(5):632-7. PubMed ID: 11369991
[TBL] [Abstract][Full Text] [Related]
28. [Poorly differentiated thyroid follicular carcinoma - a clinical analysis of 30 cases].
Liu WS; Qi YF; Tang PZ
Ai Zheng; 2004 Sep; 23(9):1081-4. PubMed ID: 15363207
[TBL] [Abstract][Full Text] [Related]
29. Extracapsular invasion of lymph node metastasis is an indicator of distant metastasis and poor prognosis in patients with thyroid papillary carcinoma.
Yamashita H; Noguchi S; Murakami N; Kawamoto H; Watanabe S
Cancer; 1997 Dec; 80(12):2268-72. PubMed ID: 9404704
[TBL] [Abstract][Full Text] [Related]
30. Cause of death in patients with well-differentiated thyroid carcinoma.
Beasley NJ; Walfish PG; Witterick I; Freeman JL
Laryngoscope; 2001 Jun; 111(6):989-91. PubMed ID: 11404609
[TBL] [Abstract][Full Text] [Related]
31. Survival in patients with papillary thyroid cancer is not affected by the use of radioactive isotope.
Podnos YD; Smith DD; Wagman LD; Ellenhorn JD
J Surg Oncol; 2007 Jul; 96(1):3-7. PubMed ID: 17567872
[TBL] [Abstract][Full Text] [Related]
32. Clinical course of insular thyroid carcinoma.
Luna-Ortiz K; Hurtado-López LM; Domínguez-Malagón H; Ramírez-Marín R; Zaldivar-Ramírez FR; Herrera-Gomez A; Barrera Franco JL
Med Sci Monit; 2004 Mar; 10(3):CR108-11. PubMed ID: 14976455
[TBL] [Abstract][Full Text] [Related]
33. [Anatomo-clinical prognostic factors of papillary carcinoma of the thyroid. Multivariate analysis: report of a series of 52 cases].
Patey M; Menzies D; Theobald S; Delisle MJ; Flament JB; Pluot M
Ann Pathol; 1998 Feb; 18(1):10-5. PubMed ID: 9551154
[TBL] [Abstract][Full Text] [Related]
34. Well differentiated thyroid carcinoma is associated with human lymphocyte antigen D-related 11 in Eastern Hungarians: a case of changing circumstances.
Juhasz F; Kozma L; Stenszky V; Gyory F; Luckas G; Farid NR
Cancer; 2005 Oct; 104(8):1603-8. PubMed ID: 16121403
[TBL] [Abstract][Full Text] [Related]
35. Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas.
Chang HY; Lin JD; Chou SC; Chao TC; Hsueh C
Jpn J Clin Oncol; 2006 Nov; 36(11):688-93. PubMed ID: 17000702
[TBL] [Abstract][Full Text] [Related]
36. Differences in tumor cell proliferation, HLA DR expression and lymphocytic infiltration in various types of thyroid carcinoma.
Lindhorst E; Schumm-Draeger PM; Bojunga J; Usadel KH; Herrmann G
Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):27-31. PubMed ID: 11835122
[TBL] [Abstract][Full Text] [Related]
37. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
[TBL] [Abstract][Full Text] [Related]
38. [Cellular immunologic parameters in thyroid diseases].
Beyer PA; Wenisch HJ; Schumm-Draeger PM; Hanisch E; Seufert RM; Encke A
Acta Med Austriaca; 1989; 16(1):6-7. PubMed ID: 2785324
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
[TBL] [Abstract][Full Text] [Related]
40. Pathologic diagnosis of papillary thyroid carcinoma: today and tomorrow.
Baloch ZW; LiVolsi VA
Expert Rev Mol Diagn; 2005 Jul; 5(4):573-84. PubMed ID: 16013975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
